We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go: Stretch investment: Withheld
Stroli – the shopping trolley reimagined for modern needs. The shopping trolley, often associated with a particular image, is an untapped category ready for innovation. The market is flooded with generic, budget-friendly options that lack charm, with the exception of Rolser, which is pricier and claims the green niche. Stroli steps in as the go-to brand, offering a unique approach, positioning, voice, and eco-friendly credentials. Say goodbye to sore hands and plastic bags – Stroli makes shopping a pleasure with its high-quality, stylish trolley bags designed to enhance your convenience and style
days to go: Extended investment: Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
10Cast forensic forecasting is a cloud and mobile AI application that integrates with legacy CRM systems to improve B2B forecasting.
days to go: Expired investment: £90,056
A fully integrated, end to end platform that enables real time situation and work force management, for the private security industry.  It ensures regulatory compliance and real time reporting for security operatives.  FalconDHQ is addressing a gap in the market to modernise the current paper based process.        
days to go: Expired investment: £415,000
Bird and Blend Tea (BABT) is a British independent tea mixologist. The company claims to offer 100+ blends of tea in a vegan-friendly product range, employs 125+ people and runs a global e-commerce platform attracting 100,000 monthly users. It claims to have achieved a £3.97 million turnover in 2020-2021 despite lockdown closures of its retail stores. BABT asserts that it operates 13 experiential retail stores across the UK since its last crowdfund in 2017. It has also featured in press entities such as The Independent, OK!, Huff Post, The Telegraph, and GQ Magazine. The company states it will use the investment to expedite the growth of its brand with investments in digital innovation, develop its technology stack, strengthen its team, open more multisensory stores, and undertake impactful projects to achieve B Corp status.
days to go: Expired investment: £999,867
Ziglu is a financial technology entity that allows a user to access both Forex and digital currencies seamlessly. The company permits a user to use any currency via its Mastercard debit card and protects the user's digital currency up to £50,000 against cyber-attacks. Ziglu is authorised by the UK's Financial Conduct Authority (FCA) as an Electronic Money Institution (EMI) and is one of the first companies involved with digital currencies to be registered under the UK’s Anti-Money Laundering Regulations (AMLR). The company has achieved a 94% rating on TrustPilot, offers customers the option to send money via cryptocurrency, and previously raised £5.25 million in seed funding. Ziglu has featured in media entities like Coindesk and Yahoo Finance. It will use 30% of the investment in product development, 60% on user acquisition, and 10% on international expansion initiatives.

Pitch Rated

84%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £3,041,878
Whitehall Finance (WF) is a Business-to-Business (B2B) financial technology platform that provides working capital to UK-based Small and Medium Enterprises (SMEs). The company offers revolving credit facility that is withdrawable in currencies like GBP, USD or EURO or a combination of the above under a single facility agreement. It also permits buying companies to offer their suppliers an early payment for a discount, as well as, enables users to access Forex services and creditworthiness data of companies. WF has extended around £16 million in finance through 1,600+ transactions over its platform in the past one year. The company will use 30% of the investment to expand its sales, 20% to increase its marketing budget, 30% to increase operational capacity to service volume business, and 20% to develop key partner relationships.

Pitch Rated

83%

Gold

rating powered by

CROWD RATING™

days to go: Expired investment: £160,027
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph